|
Standard Chartered Bank's Steve Englander analyzes market reactions to the potential passage of the Trump tax bill. He notes uncertainty in equities and the dollar. The market anticipates a benign resolution to the tariff deadline. Focus shifts to growth and profits, with AI potentially influencing market tone. The dollar's future is uncertain, influenced by yields and risk premiums.
Category:
News and Media
RBL Bank shares: The stock, which has surged over 21% in the past month and more than 64% in the last six months, extended its winning streak by rising for the eighth time in nine sessions. It closed on Tuesday at Rs 259.95, up 4.6%, with a market capitalization of Rs 15,831.21 crore.
Category:
News and Media
AstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for specific endometrial cancer cases. This follows AstraZeneca's strong Q4 earnings, with a significant jump in net profit and revenue. The company attributes this to its focus on innovation.
Category:
News and Media
All news |
||||||||||||||||||
|